ErG: 2D Pharmacophore descriptions for scaffold hopping

Journal of Chemical Information and Modeling

Volumn 46, Issue 1, 2006, Pages 208-220

  Stiefl, Nikolaus ^a,d   Watson, Ian A ^c   Baumann, Knut ^b   Zaliani, Andrea ^a  

^a Eli Lilly Research Laboratories   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c ELI LILLY AND COMPANY   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DESCRIBING FUNCTIONS; ENCODING (SYMBOLS); GRAPH THEORY; MOLECULAR DYNAMICS; MOLECULAR STRUCTURE; VECTORS;

DAYLIGHT FINGERPRINTS (DFP); EXTENDED REDUCED GRAPH APPROACH (ERG); PHARMACOPHORE; SCAFFOLD HOPPING;

DRUG PRODUCTS;

EID: 33244491039     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci050457y     Document Type: Conference Paper

References (40)

1. Bajorath, J. Virtual Screening in Drug Discovery: Methods, Expectations and Reality. Curr. Drug Discovery 2002, 3, 25-28.
2. Willett, P.; Barnard, J. M.; Downs, G. M. Chemical Similarity Searching. J. Chem. Inf. Comput. Sci. 1998, 38, 983-996.
3. Carhart, R. E.; Smith, D. H.; Venkataraghavan, R. Atom Pairs as Molecular Features in Structure-Activity Studies: Definition and Applications. J. Chem. Inf. Comput. Sci. 1985, 25, 64-73.
4. Sheridan, R. P.; Kearsley, S. K. Why do we need so many Chemical Similarity Search Methods? DDT 2002, 7, 885-931.
5. MDL Information Systems Inc., San Leandro, CA.
6. DAYLIGHT Inc., Mission Viejo, CA.
7. Jenkins, J. L.; Click, M.; Davies, J. W. A 3D Similarity Method for Scaffold Hopping from Known Drugs or Natural Ligands to New Chemotypes. J. Med. Chem. 2004, 47, 6144-6159.
8. Mason, J. S.; Good, A. C.; Martin, E. J. 3-D Pharmacophores in Drug Discovery. Curr. Pharm. Des. 2001, 7, 567-597.
9. Jilek, R. J.; Cramer, R. D. Topomers: A Validated Protocol for their Self-Consistent Generation. J. Chem. Inf. Comput. Sci. 2004, 44, 1221-1227.
10. Cramer, R. D.; Jilek, R. J.; Guessregen, S.; Clark, S. J.; Wendt, B.; Clark, R. D. "Lead Hopping". Validation of Topomer Similarity as a Superior Predictor of Similar Biological Activities. J. Med. Chem. 2004, 47, 6777-6791.
11. Rush, T. S., III.; Grant, J. A.; Mosyak, L.; Nicholls, A. A Shape-Based 3-D Scaffold Hopping Method and Its Application to a Bacterial Protein - Protein Interaction. J. Med. Chem. 2005, 48, 1489-1495.
12. Schneider, G.; Neidhart, W.; Giller, T.; Schmid, G. 'Scaffold-Hopping' by Topological Pharmacophore Search: A Contribution to Virtual Screening. Angew. Chem., Int. Ed. 1999, 38, 2894-2896.
13. Andrews, K. M.; Cramer, R. D. Toward General Methods of Targeted Library Design: Topomer Shape Similarity Searching with Diverse Structures as Queries. J. Med. Chem. 2000, 43, 1723-1740.
14. Takahashi, Y.; Sukekawa, M.; Sasaki, S. Automatic Identification of Molecular Similarity Using Reduced-Graph Representation of Chemical Structure. J. Chem. Inf. Comput. Sci. 1992, 32, 639-643.
15. Gillet, V. J.; Downs, G. M.; Ling, A.; Lynch, M. F.; Venkataram, P.; Wood, J. V. Computer Storage and Retrieval of Generic Chemical Structures in Patents. Part 8. Reduced Chemical Graphs and Their Application in Generic Chemical Structure Retrieval J. Chem. Inf. Comput. Sci. 1987, 27, 126-137.
16. Harper, G.; Bravi, G. S.; Pickett, S. D.; Hussain, J.; Green, D. V. S. The Reduced Graph Descriptor in Virtual Screening and Data-Driven Clustering of High-Throughput Screening Data. J. Chem. Inf. Comput. Sci. 2004, 44, 2145-2156.
17. Gillet, V. J.; Willett, P.; Bradshaw, J. Similarity Searching Using Reduced Graphs. J. Chem. Inf. Comput. Sci. 2003, 43, 338-345.
18. Barker, E. J.; Gardiner, E. J.; Gillet, V. J.; Kitts, P.; Morris, J. Further Development of Reduced Graphs for Identifying Bioactive Compounds. J. Chem. Inf. Comput. Sci. 2003, 43, 346-356.
19. Rarey, M.; Dixon, J. S. Feature Trees: A New Molecular Similarity Measure Based on Tree Matching. J. Comput.-Aided Mol. Des. 1998, 12, 471-490.
20. Brown, R. D.; Martin, Y. C. Use of Structure - Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection. J. Chem. Inf. Comput. Sci. 1996, 36, 572-584.
21. Martin, Y. C. 3D QSAR: Current State, Scope and Limitations. In 3D QSAR in Drug Design; Kubinyi, H., Folkers, G., Martin, Y. C., Eds.; Kluwer Academic Publishers: Dordrecht, The Netherlands, 1998; Vol. 3, pp 3-23.
22. Oprea, T. I. On the Information Content of 2D and 3D Descriptors for QSAR. J. Braz. Chem. Soc. 2002, 13, 811-815.
23. Kearsley, S. K.; Sallamack, S.; Fluder, E. M.; Andose, J. D.; Mosley, R. T.; Sheridan, R. P. Chemical Similarity Using Physiochemical Property Descriptors. J. Chem. Inf. Comput. Sci. 1996, 36, 118-127.
24. Stiefl, N.; Baumann, K. Mapping Property Distributions of Molecular Surfaces: Algorithm and Evaluation of a Novel 3D Quantitative Structure-Activity Relationship Technique. J. Med. Chem. 2003, 46, 1390-1407.
25. Physiological ionization and pKa prediction, http://www.daylight.com/ meetings/emug00/Sayle/pkapredict.html.
26. Hert, J.; Willett, P.; Wilton, D. J.; Acklin, P.; Azzaoui, K.; Jacoby, E.; Schuffenhauer, A. Comparison of Topological Descriptors for Similarity-Based Virtual Screening Using Multiple Bioactive Reference Structures. Org. Biomol. Chem. 2004, 2, 3256-3266.
27. Sheridan, R. P.; Miller, M. D.; Underwood, D. J.; Kearsley, S. K. Chemical Similarity Using Geometric Atom Pair Descriptors. J. Chem. Inf. Comput. Sci. 1996, 36, 128-136.
28. Atlas of Protein Side-Chain Interactions, http://www.biochem.ucl.ac.uk/ bsm/sidechains/index.html.
29. The RCSB Protein Data Bank, http://www.rcsb.org.
30. The MDL Drug Data Report database is available from MDL Information Systems Inc., San Leandro, CA.
31. Hert, J.; Willett, P.; Wilton, D. J.; Acklin, P.; Azzaoui, K.; Jacoby, E.; Schuffenhauer, A.; Comparison of Fingerprint-Based Methods for Virtual Screening Using Multiple Bioactive Reference Structures. J. Chem. Inf. Comput. Sci. 2004, 44, 1177-1185.
32. http://www.cheminformatics.org/
33. Chen, X.; Reynolds, C. H. Performance of Similarity Measures in 2D Fragment-Based Similarity Searching: Comparison of Structural Descriptors and Similarity Coefficients. J. Chem. Inf. Comput. Sci. 2002, 42, 1407-1414.
34. Baumann, K. An Alignment-Independent Versatile Structure Descriptor for QSAR and QSPR Based on the Distribution of Molecular Features. J. Chem. Inf. Comput. Sci. 2002, 42 (1), 26-35.
35. Mahesh, R.; Perumal, R. V.; Pandi, P. V. Pharmacophore Based Synthesis of 3-Chloroquinoxaline-2-carboxamides as Serotonin3 (5-HT3) Receptor Antagonist. Biol. Pharm. Bull. 2004, 27, 1403-1405.
36. Daveu, C.; Bureau, R.; Baglin, I.; Prunier, H.; Lancelot, J.-C.; Rault, S. Definition of a Pharmacophore for Partial Agonists of Serotonin 5-HT3 Receptors. J. Chem. Inf. Comput. Sci. 1999, 39, 362-369.
37. Takeuchi, Y.; Shands, E. F. B.; Beusen, D. D.; Marshall, G. R. Derivation of a Three-Dimensional Pharmacophore Model of Sub stance P Antagonists Bound to the Neurokinin-1 Receptor. J. Med. Chem. 1998, 41, 3609-3623.
38. Stahl, M.; Mauser, H. Database Clustering with a Combination of Fingerprint and Maximum Common Substructure Methods. J. Chem. Inf. Model. 2005, DOI: 10.1021/ci050011h.
39. Flower, D. R. On the Properties of Bit String Measures of Chemical Similarity. J. Chem. Inf. Comput. Sci. 1998, 38, 379-386.
40. Stiefl, N.; Zaliani, A. A Knowledge-based Weighting Approach to Ligand-Based Screening. Manuscript in preparation.